Inter-Observer Agreement in Assessment of Response to Neo-Adjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma

被引：0
|
作者：
Singh, Naveena
Said, Ian
Faruqi, Asma Z.
Leen, Sarah L.
Trevisan, Giorgia
Hirschowitz, Lynn
Ganesan, Raji
Vella, Jo
McCluggage, Glenn
Gilks, Blake
Boehm, Steffen
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Coll London Hosp, London, England
[3] Birmingham Womens Hosp, Birmingham, W Midlands, England
[4] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland
[5] Vancouver Gen Hosp, Vancouver, BC, Canada
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1229
引用
收藏
页码：309A / 310A
页数：2
相关论文
共 50 条
  • [41] Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
    Talhouk, Aline
    Chiu, Derek S.
    Meunier, Liliane
    Rahimi, Kurosh
    Le Page, Cecile
    Bernard, Monique
    Provencher, Diane
    Huntsman, David G.
    Masson, Anne Marie Mes
    Kobel, Martin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [42] Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
    Cohen, Paul A.
    Powell, Aime
    Bohm, Steffen
    Gilks, C. Blake
    Stewart, Colin J. R.
    Meniawy, Tarek M.
    Bulsara, Max
    Avril, Stefanie
    Brockbank, Eleanor C.
    Bosse, Tjalling
    de Azevedo Focchi, Gustavo Rubino
    Ganesan, Raji
    Glasspool, Rosalind M.
    Howitt, Brooke E.
    Kim, Hyun-Soo
    Lee, Jung-Yun
    Le, Nhu D.
    Lockley, Michelle
    Manchanda, Ranjit
    Mandalia, Trupti
    McCluggage, W. Glenn
    McNeish, Iain
    Midha, Divya
    Srinivasan, Radhika
    Tan, Yun Yi
    van der Griend, Rachael
    Yunokawa, Mayu
    Zannoni, Gian F.
    Singh, Naveena
    GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 441 - 448
  • [43] Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?
    Wilczynski, Jacek
    Paradowska, Edyta
    Wilczynski, Milosz
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [44] A Proteogenomic Analysis of Transitional Cell Carcinoma, the TCC-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn
    Karnezis, Anthony
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Soslow, Robert
    Morin, Gregg
    Hughes, Christopher
    Piskorz, Anna
    Cheng, Angela
    Greening, Kendall
    Prader, Sonja
    Pfisterer, Jacobus
    Gilks, C. Blake
    Kommoss, Stefan
    Brenton, James
    Huntsman, David
    Kommoss, Friedrich
    LABORATORY INVESTIGATION, 2019, 99
  • [45] Tubo-ovarian high-grade serous carcinomas commonly express CA19.9
    Rajendran, Simon
    McCluggage, W. Glenn
    HISTOPATHOLOGY, 2022, 80 (02) : 449 - 450
  • [46] A Proteogenomic Analysis of Transitional Cell Carcinoma, the TCC-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn
    Karnezis, Anthony
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Soslow, Robert
    Morin, Gregg
    Hughes, Christopher
    Piskorz, Anna
    Cheng, Angela
    Greening, Kendall
    Prader, Sonja
    Pfisterer, Jacobus
    Gilks, C. Blake
    Kommoss, Stefan
    Brenton, James
    Huntsman, David
    Kommoss, Friedrich
    MODERN PATHOLOGY, 2019, 32
  • [47] HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
    Koskela, Heidi
    Li, Yilin
    Joutsiniemi, Titta
    Muranen, Taru
    Isoviita, Veli-Matti
    Huhtinen, Kaisa
    Micoli, Giulia
    Lavikka, Kari
    Marchi, Giovanni
    Hietanen, Sakari
    Virtanen, Anni
    Hautaniemi, Sampsa
    Oikkonen, Jaana
    Hynninen, Johanna
    GYNECOLOGIC ONCOLOGY, 2024, 180 : 91 - 98
  • [48] Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
    Singh, Naveena
    Gilks, C. Blake
    Hirschowitz, Lynn
    Kehoe, Sean
    McNeish, Iain A.
    Miller, Dianne
    Naik, Raj
    Wilkinson, Nafisa
    McCluggage, W. Glenn
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 195 - 198
  • [49] Predicting Responses to Neoadjuvant Chemotherapy in Patients with High Grade Tubo-Ovarian Serous Carcinoma Using A Proteomic Approach
    Zare, Somaye
    Smoot, Katy
    Parkash, Vinita
    Quick, Charles
    Seeley, Erin
    Fadare, Oluwole
    MODERN PATHOLOGY, 2019, 32
  • [50] Stemness in high-grade serous carcinoma of tubo-ovarian origin causes multiple immunohistochemical pitfalls: a case report
    Van Bockstal, Mieke R.
    Augusto, David
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (12) : 845 - 846
12345